Literature DB >> 17320408

The role of the chemokine CXCL12 in osteoclastogenesis.

Stan Gronthos1, Andrew C W Zannettino.   

Abstract

The chemokine CXCL12 (variously termed stromal-derived factor 1 or B cell-stimulating factor) is a highly conserved chemotactic cytokine belonging to the large family of CXC chemokines. CXCL12 has crucial roles in the formation of multiple organ systems during embryogenesis and in the regulation of bone marrow haematopoiesis and immune function in the postnatal organism. Although considered an important factor in normal bone metabolism, recent studies implicate CXCL12 in the pathogenesis of several diseases involving the skeleton, including rheumatoid arthritis and cancers that metastasize to bone. Recent studies have highlighted an emerging role for CXCL12 in the processes of physiological and pathological bone remodelling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17320408     DOI: 10.1016/j.tem.2007.02.002

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  18 in total

1.  The Quest for Osteoporosis Mechanisms and Rational Therapies: How Far We've Come, How Much Further We Need to Go.

Authors:  Stavros C Manolagas
Journal:  J Bone Miner Res       Date:  2018-02-22       Impact factor: 6.741

Review 2.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

3.  Adipocytes enhance expression of osteoclast adhesion-related molecules through the CXCL12/CXCR4 signalling pathway.

Authors:  Tingting Luo; Hongrui Liu; Wei Feng; Di Liu; Juan Du; Jing Sun; Wei Wang; Xiuchun Han; Jie Guo; Norio Amizuka; Xianqi Li; Minqi Li
Journal:  Cell Prolif       Date:  2016-11-21       Impact factor: 6.831

4.  CXCL16 upregulates RANKL expression in rheumatoid arthritis synovial fibroblasts through the JAK2/STAT3 and p38/MAPK signaling pathway.

Authors:  Chang-hong Li; Lin-lin Xu; Jin-xia Zhao; Lin Sun; Zhong-qiang Yao; Xiao-li Deng; Rui Liu; Lin Yang; Rui Xing; Xiang-yuan Liu
Journal:  Inflamm Res       Date:  2015-11-30       Impact factor: 4.575

5.  Deregulation of the CXCL12/CXCR4 axis in methotrexate chemotherapy-induced damage and recovery of the bone marrow microenvironment.

Authors:  Kristen R Georgiou; Michaela A Scherer; Tristan J King; Bruce K Foster; Cory J Xian
Journal:  Int J Exp Pathol       Date:  2012-01-05       Impact factor: 1.925

6.  Inhibition of gluconeogenesis in primary hepatocytes by stromal cell-derived factor-1 (SDF-1) through a c-Src/Akt-dependent signaling pathway.

Authors:  Hui-Yu Liu; Ge-Bo Wen; Jianmin Han; Tao Hong; Degen Zhuo; Zhenqi Liu; Wenhong Cao
Journal:  J Biol Chem       Date:  2008-09-11       Impact factor: 5.157

Review 7.  Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge Conference.

Authors:  Robert E Coleman; Theresa A Guise; Allan Lipton; G David Roodman; James R Berenson; Jean-Jacques Body; Brendan F Boyce; Laura M Calvi; Peyman Hadji; Eugene V McCloskey; Fred Saad; Matthew R Smith; Larry J Suva; Russell S Taichman; Robert L Vessella; Katherine N Weilbaecher
Journal:  Clin Cancer Res       Date:  2008-10-15       Impact factor: 12.531

8.  Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo.

Authors:  Masaru Ishii; Junichi Kikuta; Yutaka Shimazu; Martin Meier-Schellersheim; Ronald N Germain
Journal:  J Exp Med       Date:  2010-12-06       Impact factor: 14.307

9.  Cxcl12 Deletion in Mesenchymal Cells Increases Bone Turnover and Attenuates the Loss of Cortical Bone Caused by Estrogen Deficiency in Mice.

Authors:  Filipa Ponte; Ha-Neui Kim; Srividhya Iyer; Li Han; Maria Almeida; Stavros C Manolagas
Journal:  J Bone Miner Res       Date:  2020-03-25       Impact factor: 6.741

Review 10.  Chemokines and chemokine receptors in arthritis.

Authors:  Zoltan Szekanecz; Aniko Vegvari; Zoltan Szabo; Alisa E Koch
Journal:  Front Biosci (Schol Ed)       Date:  2010-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.